Q1 2022

Filed May 23, 2022 · 10-Q · 53 days after period end · 0001493152-22-014774

Q1 2022 · 10-Q

Revenue—

Net Income

-$31.09K

N/M vs Q1 2021

EPS, diluted—

Operating Income-$31,092N/M

Operating Cash Flow-$4,864N/M

Same quarter

Metric	Q1 2022	Q1 2021	Q1 2020	Q1 2019
Revenue	—	—	$15.00K	$20.00K
Net Income	-$31.09K	-$24.24K	-$30.12K	-$29.70K
EPS Diluted	—	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR